Sabina SERIC-HARACIC, Nihad FEJZIC, Ermin SALJIC, Dzenita HADZIJUNUZOVIC-ALAGIC, Mo SALMAN

The scenario tree epidemiological model in estimation effects of B. melitensis Rev 1 vaccination on disease prevalence

The aim of this study was to evaluate the effects of the vaccination program in Bosnia and Herzegovina on annual prevalenceof small ruminant brucellosis. The stochastic scenario tree model was used to simulate vaccination and surveillance implementationduring 8 years. Outputs were annual proportions of true positive, true negative, false positive, and false negative flocks. Vaccinationcoverage was described by the Pert distribution with average 70% and min and max 50% and 80%, respectively. Effects of risk factors(high prevalence-areas and transhumance) were considered. The model was separately simulated for three levels of initial average flockprevalence (2%, 5%, and 10%). In the following years, flock prevalence arising from the fitted distribution of the false negative flocksfrom the previous year increased by the estimated reproductive number. Average within flock prevalence was provided separately for thevaccinated and unvaccinated flocks, indirectly accounting for the vaccine efficacy. Specificity of the diagnostic tests (Rose Bengal plateand Complement fixation) was reduced by 5% for the vaccinated flocks to represent the increased occurrence of false positive results.Each simulation was iterated 1000 times using @Risk, providing average prediction and 5th and 95th percentile of outputs. Accordingto our estimates, only consistent vaccination combined with systematic removal of diseased animals can result in significant reductionof disease prevalence.

PDF

___

1. Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Neglect Trop D 2012; 6: e1865.
2. McDermott J, Delia G, Zinsstag J. Economics of brucellosis impact and control in low-income countries. Rev Sci Tech OIE 2013; 32: 249-261.
3. Godfroid J, Al Dahouk S, Pappas G, Roth F, Matope G, Muma J, Marcotty T, Pfeiffer D, Skjerve E. “One Health” surveillance and control of brucellosis in developing countries: moving away from improvisation. Comp Immunol Microb 2013; 36: 241-248.
4. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-99.
5. Godfroid J, Scholz HC, Barbier T, Nicolas C, Wattiau P, Fretin D, Watmore AM, Cloeckaert A, Blasco JM, Moriyon I et al. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Prev Vet Med 2011; 102: 118- 131.
6. Mick V, Le Carrou G, Corde Y, Game Y, Jay M, Garin-Bastuji B. Brucella melitensis in France: persistence in wildlife and probable spillover from Alpine ibex to domestic animals. PLoS One 2014; 9: e94168.
7. Obradovic Z, Velic R. Epidemiological characteristics of brucellosis in Federation of Bosnia and Herzegovina. Croat Med J 2010; 51: 345-350.
8. State Veterinary Office of BiH. Operative program for brucellosis control in Bosnia and Herzegovina (small ruminant, cattle and pigs) 2008
9. Montiel DO, Bruce M, Frankena K, Udo H, van der Zijpp A, Rushton J. Financial analysis of brucellosis control for smallscale goat farming in the Bajío region, Mexico. Prev Vet Med 2015; 118: 247-259.
10. Seric-Haracic S, Salman M, Fejzic N, McCluskey BJ, Keefe TJ. Flock level risk factors for ovine brucellosis in several cantons of Bosnia and Herzegovina. HealthMED 2009; 3: 38-44.
11. Minas A, Stournara A, Minas M, Stack J, Petridou E, Christodoulopoulos G, Krikelis V. Validation of a fluorescence polarization assay (FPA) performed in microplates and comparison with other tests used for diagnosing B. melitensis infection in sheep and goats. J Immunol Methods 2007; 320: 94-103.
12. Sammartino LE, Gil A, Elzer P. Capacity building for surveillance and control of bovine and caprine brucellosis. In: Jutzi S, editor. Capacity Building For Surveillance and Control of Zoonotic Diseases. 1st ed. Rome, Italy: FAO; 2005. pp. 55-66.
13. Banai M. Control of small ruminant brucellosis by use of Brucella melitensis Rev. 1 vaccine: laboratory aspects and field observations. Vet Microbiol 2002; 90: 497-519.
14. El Idrissi AH, Benkirane A, El Maadoudi M, Bouslikhane M, Berrada J, Zerouali A. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Tech OIE 2001; 20: 741-744.
15. Lithg-Pereira PL, Mainar-Jaime RC, Alvarez-Sanchez MA, Rojo-Vazquez FA. Evaluation of official eradication-campaigns data for investigating small-ruminant brucellosis in the province of Leon, Spain. Prev Vet Med 2001; 51: 215-225.
16. Kabagambe EK, Elzer PH, Gaeghan JP, Opuda-Asibo J, Scholl DT, Miller JE. Risk factors for brucella seropositivity in goat herds in eastern and western Uganda. Prev Vet Med 2001; 52: 91-108.
17. Martin PAJ, Cameron AR, Greiner M. Demonstrating freedom from disease using multiple complex data sources: 1: a new methodology based on scenario trees. Prev Vet Med 2007; 79: 71-97.
18. Blasco JM. Control and eradication strategies for Brucella melitensis infection in sheep and goats. Prilozi 2010; 31:145-65.
19. Zinsstag J, Roth F, Orkhon D, Chimed-Ochir G, Nansalmaa M, Kolar J, Vounatsou P. A model of animal–human brucellosis transmission in Mongolia. Prev Vet Med 2005; 69: 77-95.